Feridex-labeled mesenchymal stem cells: cellular differentiation and MR assessment in a canine myocardial infarction model.
Bulte
Jeff W M
JW
Dept. of Radiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. jwmbulte@mri.jhu.edu
Kostura
Lisa
L
Mackay
Alistair
A
Karmarkar
Parag V
PV
Izbudak
Izlem
I
Atalar
Ergin
E
Fritzges
Danielle
D
Rodriguez
E Rene
ER
Young
Randy G
RG
Marcelino
Michelle
M
Pittenger
Mark F
MF
Kraitchman
Dara L
DL
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D020219:Chondrogenesis / Q000187:drug effects; D003287:Contrast Media / Q000493:pharmacokinetics / Q000633:toxicity; D003911:Dextrans; D004285:Dogs; D052203:Ferrosoferric Oxide; D006801:Humans; D007501:Iron / Q000493:pharmacokinetics / Q000633:toxicity; D008279:Magnetic Resonance Imaging / Q000379:methods*; D058185:Magnetite Nanoparticles; D059630:Mesenchymal Stem Cells / Q000737:chemistry* / Q000187:drug effects; D009203:Myocardial Infarction / Q000473:pathology / Q000628:therapy*; D010087:Oxides / Q000493:pharmacokinetics / Q000633:toxicity; D011107:Polylysine / Q000494:pharmacology; D013194:Staining and Labeling / Q000379:methods; D013552:Swine
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; D011107:Polylysine; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide